Global Anti-Cathepsin B Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global anti-cathepsin B market over the forecast period, owing to increasing research and development in anti-cathepsin B. For instance, on November 11, 2020, Spandidos Publications announced in stem-like cells from pancreatic cancer, cathepsin B is strongly expressed and is linked to surgical success in patients. Western blotting was used to demonstrate that the lysosomal cysteine protease cathepsin B (CTSB) was highly elevated in PCSLCs in comparison to that in the parental cells. Additionally, flow cytometry research proved that PCSLCs' surface expression of CTSB was higher than that of parental cells. Additionally, compared to the parental cells, PCLCs secreted more CTSB from their cells. In 69 resected tumor specimens, CTSB expression was assessed, and high expression was related to the clinicopathological characteristics of the patients and surgical results.
Anti Cathepsin B Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients